The World Economic Forum has named Berkeley Lab startup Second Genome one of its Technology Pioneers for 2017. WEF's Technology Pioneers are early stage companies anticipated to have a significant effect on business and society. Second Genome, based in South San Francisco, applies its proprietary microbiome platform to drug discovery and development. The startup's current … [Read more...] about WEF Names Second Genome a 2017 Technology Pioneer
IPO Publishes FY16 Annual Report
Berkeley Lab's Innovation and Partnerships Office (IPO) has released its first annual report highlighting technology transfer accomplishments and key IPO activities for FY16. The annual report is available online, as a pdf, or in print to share with Lab staff and potential industry partners. Contact ipo@lbl.gov for hard copies. IPO's guide to industry partnerships, published … [Read more...] about IPO Publishes FY16 Annual Report
Small Businesses to Access Berkeley Lab Expertise and Resources
The Department of Energy (DOE) selected 38 small businesses to access scientific expertise and technical resources available at DOE national labs and take steps to advance their energy-related products for the marketplace. DOE's Small Business Voucher (SBV) pilot program makes this collaboration possible, creating 114 partnerships between U. S. small businesses and the national … [Read more...] about Small Businesses to Access Berkeley Lab Expertise and Resources
Membrane Architecture for Gas and Ion Transport for Electrochemical Applications 2017-034
APPLICATIONS OF TECHNOLOGY: Reducing carbon dioxide electrochemically Producing renewable commodity chemicals and fuels ADVANTAGES: Better gas transport than liquid electrolyte Scalable design Incorporates polymers with ability to transport multiple types of ions ABSTRACT: Researchers at Cyclotron Road, a Department of Energy (DOE) Lab-Embedded … [Read more...] about Membrane Architecture for Gas and Ion Transport for Electrochemical Applications 2017-034
A Novel 12-Gene Prognostic Signature for Breast Cancer 2016-181
APPLICATIONS OF TECHNOLOGY: Targeted cancer therapies Prediction of relapse-free survival ADVANTAGES: Determines most effective treatment options for patient quality of life Standardizes breast cancer prognoses ABSTRACT: A Berkeley Lab research team led by Antoine Snijders has identified a 12-gene signature that can be used to predict relapse-free … [Read more...] about A Novel 12-Gene Prognostic Signature for Breast Cancer 2016-181